Global pharmaceutical pipeline by therapy area 2013-2017

This statistic shows the number of products in the global pharmaceutical pipeline for the period 2013-2017, broken down by therapy area. Over that period, it has been assessed that there are 53 pharmaceutical products in the pipeline for tuberculosis. It is evident that (ischaemic) heart disease, cancer and diabetes are the three top therapeutic areas regarding the R&D pipeline.

本统计数据显示了2013年至2017年全球药品研发管线中产品的数量，按治疗领域进行细分。在该期间内，据评估，针对结核病的药品研发管线中共有53种药品。显而易见，就研发管线而言，缺血性心脏病、癌症和糖尿病是三大主要治疗领域。